Wayne Shiong

Wayne Shiong is a Partner at China Growth Capital, specializing in frontier technologies, particularly in computing and life sciences, with notable investments including WeRide. Shiong holds board member positions at multiple companies, including 睿心医疗, which focuses on AI-based imaging diagnostics for cardiovascular patients; PVmed, which targets cancer diagnostics; and 华科精准 (Beijing) Medical Technology Co., Ltd., known for its advanced surgical robotics for neurosurgery. Additional board memberships include 4B Technologies, Ltd. for neurodegenerative disease solutions and InxMed for cancer treatment innovations. Shiong has also invested in companies like 壁仞科技, leading in GPU technology, and Singleron Biotechnologies. Shiong earned a B.A. in Economics from Peking University and completed an Executive Development Program at INSEAD.